Has Jason Taylor, DO received payments from drug or device companies?

Yes. Drug and device makers reported $1,062 in general payments to Jason Taylor, DO across 61 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Jason Taylor, DO did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Jason Taylor, DO come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Jason Taylor, DO

Family Medicine · Norman, OKNPI 1740448620

Payments from drug & device makers

$1,062in general payments, 2019–2025

Across 61 payments — averaging $17.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Novo Nordisk$175
Lilly USA, LLC$116
AstraZeneca$102
Johnson & Johnson$92
Exact Sciences$77
Takeda Pharmaceuticals U.S.A., Inc.$76
plus $424 from 15 others

What the payments were for

Food & beverage$1,062100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Novo Nordisk	10	$175
Lilly USA, LLC	7	$116
AstraZeneca	7	$102
Johnson & Johnson	5	$92
Exact Sciences	5	$77
Takeda Pharmaceuticals U.S.A., Inc.	3	$76
Sumitomo Pharma America, Inc.	3	$57
Otsuka America Pharmaceutical, Inc.	2	$47
GSK	3	$47
AbbVie	2	$44
Idorsia Pharmaceuticals US Inc	2	$35
Amgen	2	$33
Phathom Pharmaceuticals, Inc.	2	$29
Merck	1	$22
Optinose US, Inc.	1	$20
Portola Pharmaceuticals, LLC	1	$19
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	1	$15
Impel Pharmaceuticals Inc.	1	$15
Xeris Pharmaceuticals, Inc.	1	$14
Boehringer Ingelheim	1	$14
E.r. Squibb & Sons, L.L.C.	1	$14

How this compares

$1,062 in reported general payments places this provider in the 65th percentile of 1,730 family medicine providers in Oklahoma.

See all family medicine providers in Oklahoma →

Medicare billing

Part B allowed, 2024

$48,908

Medicare patients

412

Services billed

1,029

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Doxycycline Hyclate	81	$786
Methylprednisolone	70	$573
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav	44	$542
Cefdinir	38	$485
Azithromycin	85	$391
Cephalexin	36	$307
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst	21	$271
Ciprofloxacin Hcl	24	$193
Fluconazole	17	$182
Prednisone	93	$176
Mupirocin	19	$125
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim	12	$83
PaxlovidNirmatrelvir/Ritonavir	14	$0

Paid to pharmacies, not to this prescriber.

Other family medicine in Norman

Lisa ConneryNorman$15.6M
Steven CoxNorman$6.9M
Rachel AndersonNorman$2.8M
Carl GriffinOklahoma City$28.2M
Kyle RicknerYukon$14.7M
Robert LockwoodYukon$8.6M
Alexander FrankOklahoma City$3.1M
Robert WestcottLindsay$1.6M
Charles LunnOklahoma City$1.4M
Jeffrey ChasteenTulsa$820K

See the full list for Oklahoma →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →